No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies (Q37367952)
Jump to navigation
Jump to search
scientific article published on 26 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies |
scientific article published on 26 July 2016 |
Statements
1 reference
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies (English)
1 reference
Helen M Colhoun
1 reference
Henry N Ginsberg
1 reference
Jennifer G Robinson
1 reference
Lawrence A Leiter
1 reference
Dirk Müller-Wieland
1 reference
Robert R Henry
1 reference
Bertrand Cariou
1 reference
Marie T Baccara-Dinet
1 reference
Robert Pordy
1 reference
Laurence Merlet
1 reference
Robert H Eckel
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference